Theme |
Can we change to treat for diminutive colorectal polyp ? |
Title |
Pros and cons of "Resect and Discard" trial -- from a conventional and magnifying endoscopic standpoint |
Author |
Yoji Takeuchi |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Masao Hanafusa |
Department of Gastroenterology and Hepatology, Akashi Medical Center |
Author |
Takeshi Yamashina |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Takashi Ito |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Noriko Matsuura |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Koji Higashino |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Noriya Uedo |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Ryu Ishihara |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
Author |
Hiroyasu Iishi |
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases |
[ Summary ] |
The Resect and Discard strategy is a promising proposal, because of the possibility to reduce medical expenses. However it also has limitations, which include the possibility of discarding small invasive cancer samples and neglecting advanced histology. We proposed the "DISCARD-ME" policy, which is a new resect and discard strategy using magnifying endoscopy taking into consideration advanced histology. We believe that we should try to reduce medical expenses using this promising diagnostic technique, because increased medical expenses are a common problem around the world. |